ALNYLAM PHARMACEUTICALS, INC. (32) | Business Finance (6)
Browse by Subcategory
Recent Contracts
-
Amendment No. 1 to Co-Development Agreement between the Registrant and BXLS V Bodyguard PCP L.P. and BXLS Family Investment Partnership V ESC L.P. dated November 23, 2021
(Filed With SEC on February 10, 2022)
-
Purchase and Sale Agreement dated April 10, 2020 between BX Bodyguard Royalties L.P. and the Registrant
(Filed With SEC on August 6, 2020)
-
Description of Capital Stock
(Filed With SEC on February 13, 2020)
-
Underwriting Agreement, dated January 14, 2019, between Alnylam Pharmaceuticals, Inc. and Barclays Capital Inc
(Filed With SEC on January 15, 2019)
-
Stock Purchase Agreement dated as of April 8, 2019 by and between the Registrant and Regeneron Pharmaceuticals, Inc
(Filed With SEC on August 6, 2019)
-
Amended and Restated 2004 Employee Stock Purchase Plan, as amended
(Filed With SEC on May 2, 2019)